Gen9

Gen9 is a privately held company based in Cambridge, Massachusetts, that specializes in next-generation gene synthesis technology. Founded in 2009 by leading experts in synthetic biology, Gen9 focuses on automating the production of DNA constructs with high throughput, accuracy, and cost-effectiveness. The company's innovations significantly enhance the capacity for DNA content production, enabling advancements in various industries, including pharmaceuticals, enzyme and chemical production, and biofuels. Through its scalable fabrication capabilities, Gen9 aims to promote the constructive application of synthetic biology, ultimately contributing to the improvement of genes, pathways, genomes, and organisms.